In the realm of specialized chemicals, understanding the fundamental properties and applications of each compound is key to unlocking its full potential. 3-(4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione, identified by its CAS number 827026-45-9, is one such compound that holds significant importance, particularly within the pharmaceutical industry. Its complex structure, featuring a nitro group and multiple carbonyls within a heterocyclic framework, positions it as a valuable pharmaceutical intermediate and a critical research tool.

The chemical properties of this compound include its designation as a beige to brown solid with a high melting point, often exceeding 250°C. This physical characteristic is important for its handling and storage, ensuring stability during chemical processes. The synthesis of 3-(4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione is a subject of considerable interest for organic chemists. The precision required for its preparation, particularly in achieving high purity levels, is a hallmark of advanced pharmaceutical intermediate synthesis. Companies looking to buy this compound often seek manufacturers that can guarantee batch-to-batch consistency.

Its significance is further amplified by its relationship with Lenalidomide, serving as both an analog and a potential impurity. This dual role makes it an indispensable component in the quality control and assurance processes of pharmaceutical manufacturing. By utilizing it as a reference standard, researchers and manufacturers can rigorously test drug products for purity and efficacy. The availability of such precise chemical research reagents is fundamental to maintaining high standards in drug development.

Furthermore, the compound's structural similarity to Lenalidomide opens avenues for further research in medicinal chemistry. Scientists can explore modifications or derivatives based on this scaffold to develop new therapeutic agents. The reliable supply of these complex molecules by entities like NINGBO INNO PHARMCHEM CO.,LTD. is crucial for fostering innovation in the pharmaceutical sector. The strategic importance of such intermediates underscores the need for robust chemical supply chains to support ongoing advancements in healthcare.